Fifth AMENDMENT and Waiver TO CREDIT AGREEMENTCredit Agreement • November 5th, 2024 • Verrica Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 5th, 2024 Company Industry JurisdictionThis FIFTH AMENDMENT AND WAIVER TO CREDIT AGREEMENT (this “Amendment”) is made and entered into as of August 2, 2024 by and among VERRICA PHARMACEUTICALS INC., a Delaware corporation (the “Borrower”), the Lenders party hereto (the “Lenders”), and ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP, as administrative agent for the Lenders (together with its Affiliates, successors, transferees and assignees, the “Administrative Agent”).
Fifth AMENDMENT and Waiver TO CREDIT AGREEMENTCredit Agreement • August 14th, 2024 • Verrica Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 14th, 2024 Company Industry JurisdictionThis FIFTH AMENDMENT AND WAIVER TO CREDIT AGREEMENT (this “Amendment”) is made and entered into as of August 2, 2024 by and among VERRICA PHARMACEUTICALS INC., a Delaware corporation (the “Borrower”), the Lenders party hereto (the “Lenders”), and ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP, as administrative agent for the Lenders (together with its Affiliates, successors, transferees and assignees, the “Administrative Agent”).